Top

Published in:

2020 | OriginalPaper | Chapter

18. The Cost of Parkinson’s Disease: A Systematic Review

Authors : Sávio Luís Oliveira da Silva, Oswaldo Luiz Gonçalves Quelhas, Julio Vieira Neto, Marco Antônio Araújo Leite

Published in: Operations Management for Social Good

Publisher: Springer International Publishing

Activate our intelligent search to find suitable subject content or patents.

search-config

AI-assisted search

Off

Abstract

Determining the costs of a disease facilitates the understanding and evaluation of their impact with its main stakeholders. The aim of this literature review is to deepen the studies on the individual costs of Parkinson’s disease, reinforcing the understanding of its impacts on the healthcare system.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

previous chapter The Use of Big Data for Researching the Leprosy Healthcare Supply Chain

next chapter A New Framework to Develop Healthcare Decision Support Systems in the Military Context

Bovolenta, T.M., Silva, S.M.C.A., Saba, R.A., Borges, V., Ferraz, H.B., Felicio, A.C.: Average annual cost of Parkinson’s disease in São Paulo, Brazil, with a focus on disease-related motor symptoms. Clin. Interv. Aging 12, 2095–2108 (2017)

Bovolenta, TM., Silva, S.M.C.A., Saba, R.A., Borges, V., Ferraz, H,B., Felicio, A.C.: Systematic review and critical analysis of cost studies associated with Parkinson’s Disease. Hindawi Parkinson’s Disease, 1–11 (2017)

Brasil. Ministério da Saúde.: Avaliação econômica em saúde: desafios para gestão no Sistema Único de Saúde. Ministério da Saúde, Brasília (2008)

Cubo, E., Alvarez, E., Morant, C., Cuesta, J.P., Martín, P.M., Génova, R., Freire, J.M.: Burden of disease related to Parkinson’s Disease in Spain in the Year 2000. Mov. Disord. 20(11), 1481–1487 (2005)CrossRef

Daneault, J.F., Carignan, B., Sadikot, A.F., Panisset, M., Duval, C.: Drug-induced dyskinesia in Parkinson’s disease: should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia? BMC Med. 11(73), 1–18 (2013)

Findley, L.J.: The economic impact of Parkinson’s disease. Parkinsonism and Relat. Disord. 13, S8–S12 (2007)CrossRef

García-Ramos, R., Valdés, E.L., Ballesteros, L., Jesús, S., Mir, P.: The social impact of Parkinson’s disease in Spain: report by the Spanish foundation for the brain. Neurología 31(6), 401–413 (2016)CrossRef

Gaskin, J., Gomes, J., Darshan, S., Krewski, D.: Burden of neurological conditions in Canada. NeuroToxicology 61, 2–10 (2017)CrossRef

Gil-Prieto, R., Pascual-Garcia, R., San-Roman-Montero, J., Martínez-Martin, P., Castrodeza-Sanz, J., Gil-de-Miguel, A.: Measuring the burden of hospitalization in patients with Parkinson’s Disease in Spain. PLoS ONE 11(3), 1–11 (2016)CrossRef

10.

Jaglal, S.B., Guilcher, S.J.T., Bereket, T., Kwan, M., Munce, S., Conklin, J., Versnel, J., Packer, T., Verrier, M., Marras, C., Pitzul, K.B., Riopelle, R.: Development of a Chronic Care Model for Neurological Conditions (CCM-NC). BMC Health Serv. Res. 14, 1–12 (2014)CrossRef

11.

Johnson, S.J., Diener, M.D., Kaltenboeck, A., Birnbaum, H.G., Grubb, E., Siderowf, A.D.: An economic model of Parkinson’s disease: implications for slowing progression in the United States. Mov. Disord. 28(3), 319–326 (2013)

12.

Johnson, S.J., Kaltenboeck, A., Diener, M.D., Birnbaum, H.G., Grubb, E., Castelli-Haley, J., Siderowf, A.D.: Costs of Parkinson’s disease in a privately insured population. PharmacoEconomics 31, 799–806 (2013)

13.

Koay, L., Rose, J., Abdelhafiz, A.H.: Factors that lead to hospitalisation in patients with Parkinson disease—a systematic review. Int. J. Clin. Pract. 72, 1–5 (2018)CrossRef

14.

Kowal, S.L., Dall, T.M., Chakrabarti, R., Storm, M.V., Jain, A.: The current and projected economic burden of Parkinson’s disease in the United States. Mov. Disord. 28(3), 311–318 (2013)CrossRef

15.

Lindgren, P., von Campenhausen, S., Spottke, E., Siebert, U., Dodel, R.: Cost of Parkinson’s disease in Europe. Eur. J. Neurol. 12(Suppl. 1), 68–73 (2005)CrossRef

16.

Martínez-Martin, P., Rodriguez-Blazquez, C., Paz, S., Forjaz, M.J., Frades-Payo, B., Cubo, E., Pedro-Cuesta, J., Lizán, L.: Parkinson symptoms and health related quality of life as predictors of costs: a longitudinal observational study with linear mixed model analysis. PLoS ONE 10(12), 1–16 (2015)CrossRef

17.

Moraz, G., Garcez, A.S., Assis, E.M., Santos, J.P., Barcellos, N.T., Kroeff, L.R.: Estudos de cisto-efetividade em saúde no Brasil: uma revisão sistemática. Ciência & Saúde Coletiva 20(10), 3211–3229 (2015)

18.

Mudiyanselage, S.B., Watts, J.J., Ochom, J.A., Lane, L., Murphy, A.T., Morris, M.E., Iansek, R.: Cost of living with Parkinson’s disease over 12 months in Australia: a prospective cohort study. Hindawi Parkinson’s Disease 1–14 (2017)

19.

Oliveira, M.L., Santos, L.M.P., Silva, E.N.: Bases metodológicas para estudos de custos da doença no Brasil. Rev Nutr 27(5), 585–595 (2014)CrossRef

20.

Pinto, M., Ugá, M.A.D.: O custo de doenças tabaco-relacionadas para o Sistema Único de Saúde. Cad Saúde Pública 26(6), 1234–1245 (2010)CrossRef

21.

Richy, F.F., Pietri, G., Moran, K.A., Senior, E., Makaroff, L.E.: Compliance with pharmacotherapy and direct healthcare costs in patients with Parkinson’s disease: a retrospective claims database analysis. Appl. Health Econ. Health Policy 11, 395–406 (2013)CrossRef

22.

Rodríguez-Blázquez, C., Forjaz, M.J., Lizán, L., Paz, S., Martínez-Martín, P.: Estimating the direct and indirect costs associated with Parkinson’s disease. Expert Rev. Pharmacoeconomics Outcomes Res 1–23 (2015)

23.

Schlatter, R.P.: Estudo de custos em doenças crônicas não transmissíveis: manejo da cardiopatia isquêmica e diagnostic precoce de cancer hereditário. Doctoral Thesis. Federal University of Rio Grande do Sul, Brasil (2016)

24.

Secoli, S.R., Nita, M.E., Ono-Nita, S.K., Nobre, M.: Avaliação de tecnologia em saúde. II. A análise de custo-efetivida-de. Arq Gastroenterol 47(4), 329–333 (2010)

25.

Segel, J.E.: Cost-of-Illness studies: a primer. [s.l.]: RTI International. RTI-UNC Center of Excellence in Health Promotion Economics (2006)

26.

Silva, E.N., Silva, M.T., Pereira, M.G.: Identificação, mensuração e valoração de custos em saúde. Epidemiol Serv Saúde 25(2), 437–439 (2016)

27.

Tamás, G., Gulácsi, L., Bereczki, D., Baji, P., Takáts, A., Brodzky, V., Péntek, M.: Quality of life and costs in Parkinson’s disease: a cross sectional study in Hungary. PLoS ONE 9(9), 1–7 (2014)CrossRef

28.

Vanni, T., Luz, P.M., Ribeiro, R.A., Novaes, H.M.D., Polanczyk, C.A.: Avaliação econômica em saúde: aplicações em doenças infecciosas. Cad. Saúde Pública 25(12), 2543–2552 (2009)CrossRef

29.

von Campenhausen, S., Winter, Y., Silva, A.R., Sampaio, C., Ruzicka, E., Barone, P., Poewe, W., Guekht, A., Mateus, C., Pfeiffer, K.P., Berger, K., Skoupa, J., Botzel, K., Geiger-Gritsch, S., Siebert, U., Balzer-Geldsetzer, M., Oertel, W.H., Dodel, R., Reese, J.P.: Costs of illness and care in Parkinson’s disease: an evaluation in six countries. Eur. Neuropsychopharmacol. 21, 180–191 (2011)CrossRef

30.

Watts, J.J., McGinley, J.L., Huxham, F., Menz, H.B., Iansek, R., Murphy, A.T., Waller, E.R., Morris, M.E.: Cost effectiveness of preventing falls and improving mobility in people with Parkinson disesase: protocol for an economic evaluation alongside a clinical trial. BMC Geriatrics 8(23), 1–8 (2008)

31.

Weir, S., Samnaliev, M., Kuo, T.C., Tierney, T.S., Autiero, S.W., Taylor, R.S., Schrag, A.: Short- and long-term cost and utilization of health care resources in Parkinson’s disease in the UK. Mov. Disord. 33(6), 974–981 (2018)CrossRef

32.

Winter, Y., von Campenhausen, S., Brozova, H.: Costs of Parkinson’s disease in Eastern Europe: a Czech cohort study. Parkinsonism and Relat. Disorders 16(1), 51–56 (2010)CrossRef

33.

Yang, J.X., Chen, L.: Economic burden analysis of Parkinson’s disease patients in China. Hindawi Parkinson’s Disease 1–7 (2017)

34.

Yoritaka, A., Fukae, J., Hatano, T., Oda, E., Hattori, N.: The direct cost of Parkinson disease at Juntendo medical university hospital, Japan. Intern. Med. 55(2), 113–119 (2016)CrossRef

35.

Yu, W., Ravelo, A., Wagner, T.H., Barnett, P.G.: The relationships among age, chronic conditions, and healthcare costs. Am. J. Managed Care 10(12), 909–916 (2004)

36.

Zhao, Y.J., Tan, L.C.S., Li, S.C., Au, W.L., Seah, S.H., Lau, P.N., Luo, N., Wee, H.L.: Economic burden of Parkinson’s disease in Singapore. Eur. J. Neurol. 18, 519–526 (2011)

Title: The Cost of Parkinson’s Disease: A Systematic Review
Authors: Sávio Luís Oliveira da Silva
Oswaldo Luiz Gonçalves Quelhas
Julio Vieira Neto
Marco Antônio Araújo Leite
Publisher: Springer International Publishing
Book: Operations Management for Social Good
Print ISBN: 978-3-030-23815-5

Electronic ISBN: 978-3-030-23816-2

Copyright Year: 2020
DOI: https://doi.org/10.1007/978-3-030-23816-2_18